Bone marrow disorders Flashcards

1
Q

What is polycythaemia?

A

An increase in Hb concentration above the upper limit for a person’s age and sex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is polycythaemia classified?

A

Relative (normal red cell mass but LOW PLASMA VOLUME) and absolute (true) polycythaemia (raised red cell mass)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the aetiology of absolute polycythaemia? (x2 (x3 and x5))

A
  • PRIMARY: polycythaemia vera or polycythaemia rubra vera is when excess RBCs are produced by the bone marrow.
  • SECONDARY: APPROPRIATE INCREASED ERYTHROPOIETIN caused by chronic hypoxia (for example, chronic lung disease, sleep apnoea or altitude) leasing to upregulation of erythropoiesis. INAPPROPRIATE INCREASED ERYTHROPOIETIN caused by renal carcinoma, renal cysts, hepatocellular carcinoma, fibroids, cerebellar hemangioblastoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is polycythaemia vera?

A

Neoplastic clonal haematopoietic disorder characterised clinically by erythrocytosis and often thrombocytosis, leukocytosis, and splenomegaly. Aka polycythaemia rubra vera.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathophysiology of polycythaemia vera?

A

In 95% of cases, a JAK2 tyrosine kinase mutation gives haematopoietic stem cells in the bone marrow a proliferative advantage causing a trilineage expansion of morphologically normal RBCs, WBCs and platelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the aetiology of relative polycythaemia? (x2)

A

Dehydration, Gaisbock’s syndrome (seen in young male smokers with raised vasomotor tone and hypertension resulting in reduced plasma volume and relative increase in RBC count).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the epidemiology of polycythaemia: Incidence? Age?

A

Polycythaemia rubra vera has annual UK incidence of 1.5 in 100 000. Peak age is 45-60 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the signs and symptoms of polycythaemia? How is this related to pathophysiology? (x10 +6) How ‘Bout DaT, TPPSSH (sassy ‘tutting’)

A
  • Related to hyper viscosity: headaches, dyspnoea, tinnitus, blurred vision
  • Thrombosis (from hyperviscosity and pro-inflammatory environment produced by raised WCC)
  • Plethoric complexion (red)
  • Pruritus after hot bath, night sweats
  • Splenomegaly in 75% of patients
  • Hypertension
  • Pain from peptic ulcer disease, conjunctival suffusion (redness like in conjunctivitis without inflammatory exudate), retinal venous engorgement, angina, gout, choreiform movements (jerky)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does FBC show in polycythaemia? (x3)

A

Raised Hb, raised Hct, low MCV (because most also present with iron deficiency anaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What additional investigations are there in polycythaemia vera? (x4)

A
  • FBC also shows raised WCC, platelets, decreased serum erythropoietin
  • JAK2 mutation screen – present in almost all but not specific to polycythaemia vera
  • Bone marrow trephine biopsy – shows erythroid hyperplasia and raised megakaryocytes
  • USS showing splenomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What additional investigations are there for secondary polycythaemia? (x3)

A
  • Raised erythropoietin
  • Pulse oximetry, ABG and CXR to exclude chronic lung disease
  • Abdominal CT or brain MRI to look for erythropoietin-secreting tumours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How are isotope dilution techniques used to investigate polycythaemia?

A

Infusion of radiolabelled albumin and RBCs allow confirmation of plasma volume and red cell mass and distinguish between relative (low PV, normal RCM) and absolute (normal PV, raised RCM) polycythaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is myelofibrosis?

A

Disorder of haematopoietic stem cells characterised by abnormal production of RBCs, WBCs and platelets, in association with progressive marrow fibrosis, extramedullary haematopoiesis (outside medulla of bone) and splenomegaly. It is REACTIVE and REVERSIBLE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the aetiology of myelofibrosis? (x1 and x4)

A
  • Primary myelofibrosis – unknown aetiology characterised by leukoerythroblasts (myeloid cell precursor – gives rise to erythrocytes, multinucleated WCCs and platelets) and splenomegaly
  • Secondary myelofibrosis – reactive to malignant bone marrow disorders such as leukaemia, benign bone marrow disorders such as polycythaemia vera, hypothyroidism or drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the pathophysiology of primary myelofibrosis? (x4 points)

A
  • Thrombocytosis and megakaryocytic dysplasia and clustering leads to cytokine release, fibroblast proliferation and collagen deposition in bone marrow
  • This also causes extramedullary haematopoiesis mostly in liver and spleen
  • Circulating levels of TGF-beta are increased which impairs osteoclast formation and promotes osteosclerosis (abnormal bone hardening).
  • There is also increased marrow angiogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What other pathology may cause extramedullary haematopoiesis?

A

Thalassaemia.

17
Q

What is the epidemiology of myelofibrosis: Age? Gender?

A

50-70 years is peak age of onset. Males predominantly affected, though girls more affected if diagnosed when young.

18
Q

What are the signs and symptoms of myelofibrosis? (x5)

A
  • Constitutional symptoms from hypercatabolic state (high energy output): weight loss, fever, night sweats, pruritus
  • Splenomegaly present in almost all patients, with 50% also with hepatomegaly. Splenomegaly may present with LUQ pain.
  • Signs of extramedullary haematopoiesis: haemorrhage at site of haematopoiesis e.g., GI tract, haematuria, haemoptysis, spinal cord compression etc.
  • Bone pain from osteosclerosis
  • Bleeding from thrombocytopenia
19
Q

What are the investigations in myelofibrosis? (x5 +3)

A
  • BLOOD: anaemia later in disease progression, with leukopenia and thrombocytopenia. LFTs may be abnormal in hepatomegaly
  • BLOOD FILM: leucoerythroblastic changes (teardrop red blood cells (black arrows), myelocyte (red arrow), promyelocyte (blue arrow) and nucleated RBCs)
  • BONE MARROW ASPIRATE: an unsuccessful aspiration (‘dry’ tap) is characteristic
  • BONE MARROW BIOPSY: shows fibrotic hypercellular marrow, with dense reticulum (type III collagen) fibres on silver staining
  • Coomb’s test positive
  • Autoimmune phenomena such as ANA and RF are characteristic
  • Elevated CD34+ cells characteristic
20
Q

What is myelodysplasia?

A

Haematological conditions characterised by ineffective/dysplastic haematopoiesis resulting in at least one chronic cytopenia (anaemia, neutropenia, thrombocytopenia) and abnormal cellular maturation. AKA MDS (myelodysplastic syndromes).

21
Q

What is the aetiology of myelodysplasia?

A
  • Primary
  • Chemotherapy or radiotherapy for previous malignancies
  • Chromosomal abnormalities – deletions are most common (in Chr5,7,11,12,13 and 20), monosomy 7, trisomy 8 or complex karyotypes with multiple abnormalities
22
Q

What risk factors are there for myelodysplasia? (x7)

A

Smoking and benzene exposure. Congenital neutropenia, Down’s syndrome, Fanconi’s anaemia, xeroderma pigmentosum, aplastic anaemia.

23
Q

What is the pathophysiology of myelodysplasia?

A

There is creation of a neoplastic multipotent haematopoietic stem cell which produces defective cells prone to apoptosis. As such, most die before reaching maturity, bone marrow responds by increasing its activity leading to hyperplasia, but cytopenia still occurs because of the defect introduced by the neoplastic clone.

24
Q

What are the types of myelodysplasia? (x5)

A
  • MDS with single lineage dysplasia (MDS-SLD): less than 5% blasts in bone marrow
  • MDS with multilineage dysplasia (MDS-MLD): less than 5% blasts in bone marrow but 2 or 3 dysplastic lineages and at least 1 cytopenia
  • MDS with ringed sideroblasts and single lineage dysplasia (MDS-RS-SLD): less than 5% blasts in bone marrow and at least 15% ringed sideroblasts in blood
  • MDS with ringed sideroblasts and multilineage dysplasia (MDS-RS-MLD): less than 5% blasts in bone marrow and at least 15% ringed sideroblasts in blood. 2 or 3 dysplastic lineages and at least 1 cytopenia
  • MDS with excess blasts: can be multi or single lineage, between 5 and 20% blasts in bone marrow.
25
Q

What does a patient have if over 20% blasts in bone marrow?

A

Patient considered to have AML.

26
Q

What are ringed sideroblasts?

A

Erythrocyte precursor with nucleus and granules of iron in mitochondria.

27
Q

What is the epidemiology of myelodysplastic syndromes: Age? Gender?

A

65-75 years old. More common in males.

28
Q

What are the signs and symptoms of myelodysplastic syndromes?

A
  • Asymptomatic
  • BONE MARROW FAILURE: anaemia, neutropenia (recurrent infections), thrombocytopenia (easy bruising, epistaxis)
  • Hepatosplenomegaly and lymphadenopathy except in a type of MDS called chronic myelomonocytic leukaemia (CMML) which is characterised by up to 20% blasts in bone marrow and elevated peripheral blood monocyte count
29
Q

What are the investigations for MDS? (x4)

A
  • FBC: pancytopenia.
  • Erythropoietin high
  • BLOOD FILM: normocytic/macrocytic red cells, ovalomacrocytosis, variable microcytic red cells in MDS-RS, reduced/absent granulation (WCCs with granules include eosinophils, neutrophiles), raised monocytes (in CMML), and myeloblasts
  • BONE MARROW ASPIRATE/BIOPSY: hypercellularity, ringed sideroblasts, abnormal granulocyte precursors and megakaryocytes.